NCT06473233View on ClinicalTrials.gov

Interest of TEG6S® in Reducing Transfusion Needs During Postpartum Haemorrhage

CompletedOBSERVATIONAL
Enrollment

195

Participants

Timeline

Start Date

October 9, 2024

Primary Completion Date

March 6, 2025

Study Completion Date

March 6, 2025

Conditions
Postpartum Hemorrhage
Interventions
DEVICE

TEG6S

Hemostatic management including one or more delocalized biology test with the TEG6S®, at the discretion of the responsible clinician

Trial Locations (1)

91106

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

All Listed Sponsors
lead

Centre Hospitalier Sud Francilien

OTHER

NCT06473233 - Interest of TEG6S® in Reducing Transfusion Needs During Postpartum Haemorrhage | Biotech Hunter | Biotech Hunter